MultiplAI Health

About:

MultiplAI Health is a leveraging advances in genomics and artificial intelligence to develop universal remote screening.

Website: https://multiplaihealth.com/

Twitter/X: multiplaihealth

Top Investors: Zentynel Frontier Investments, HeartX, First In Ventures, SF500, Greater London Authority

Description:

MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases among other complex diseases. We use a liquid biopsy of whole blood based on RNA sequencing and deep learning looking at all biomarkers in the blood, thus creating a superb biomarker to detect diseases earlier. Our test can be used in continuous testing both for preventative screening and post-treatment monitoring. Given that it requires only a simple blood sample, it can be administered remotely, anywhere, and costs a fraction of existing diagnostic methods.

Total Funding Amount:

2.25M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2019-10-01

Contact Email:

info(AT)multiplaihealth.com

Founders:

Charlie Luzzani, Mark Ramondt, Santiago Miriuka

Number of Employees:

11-50

Last Funding Date:

2024-09-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai